Exome Asset Management LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Exome Asset Management LLC disclosed 52 US equity positions worth $162.1m in its Q2 2026 13F filing. The largest position was GH at 6.2% of the reported book, followed by PRAX and TGTX. Against the Q1 2026 filing, it opened 14 new positions, added to 1 and reduced 31 among the top 50 holdings.
What did Exome Asset Management LLC own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | GH GUARDANT HEALTH INC | Healthcare | 6.2% | $10.1m | 67,500 | -18% | reduced |
| 2 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 5.6% | $9.1m | 27,205 | -40% | reduced |
| 3 | TGTX TG THERAPEUTICS INC | Healthcare | 5.6% | $9.1m | 164,915 | – | new |
| 4 | COGT COGENT BIOSCIENCES INC | Healthcare | 5.0% | $8.1m | 210,523 | -24% | reduced |
| 5 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 4.3% | $7.0m | 88,177 | -20% | reduced |
| 6 | LLY ELI LILLY & CO | Healthcare | 4.1% | $6.6m | 5,492 | -22% | reduced |
| 7 | ABVX ABIVAX SA | Healthcare | 3.9% | $6.2m | 46,878 | – | new |
| 8 | ALMS ALUMIS INC | Healthcare | 3.5% | $5.8m | 204,418 | -27% | reduced |
| 9 | CYTK CYTOKINETICS INC | Healthcare | 3.2% | $5.1m | 60,056 | -42% | reduced |
| 10 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 3.1% | $5.1m | 100,203 | -54% | reduced |
| 11 | VERA VERA THERAPEUTICS INC | Healthcare | 2.6% | $4.2m | 97,276 | -15% | reduced |
| 12 | UNH UNITEDHEALTH GROUP INC | Healthcare | 2.5% | $4.0m | 9,612 | -25% | reduced |
| 13 | TXG 10X GENOMICS INC | Healthcare | 2.4% | $3.9m | 102,629 | -33% | reduced |
| 14 | NTRA NATERA INC | Healthcare | 2.3% | $3.7m | 13,800 | -26% | reduced |
| 15 | UNIQURE NV | 2.3% | $3.7m | 81,056 | – | new | |
| 16 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 2.2% | $3.6m | 32,209 | -21% | reduced |
| 17 | MAZE MAZE THERAPEUTICS INC | Healthcare | 2.1% | $3.4m | 114,692 | 30% | added |
| 18 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 2.0% | $3.3m | 137,115 | -24% | reduced |
| 19 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 2.0% | $3.2m | 166,493 | -23% | reduced |
| 20 | ALKS ALKERMES PLC | Healthcare | 2.0% | $3.2m | 61,336 | -27% | reduced |
| 21 | LQDA LIQUIDIA CORPORATION | Healthcare | 1.9% | $3.1m | 39,224 | -14% | reduced |
| 22 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.8% | $2.9m | 5,410 | -23% | reduced |
| 23 | GKOS GLAUKOS CORP | Healthcare | 1.7% | $2.8m | 19,862 | -5% | reduced |
| 24 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.6% | $2.6m | 32,214 | -30% | reduced |
| 25 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.6% | $2.6m | 70,500 | -44% | reduced |
| 26 | CBIO CRESCENT BIOPHARMA INC. | 1.4% | $2.3m | 127,769 | -17% | reduced | |
| 27 | AZN ASTRAZENECA PLC | Healthcare | 1.4% | $2.3m | 12,045 | – | new |
| 28 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.3% | $2.1m | 48,347 | 0% | held |
| 29 | ADAG ADAGENE INC | 1.3% | $2.1m | 488,293 | -34% | reduced | |
| 30 | PEN PENUMBRA INC | Healthcare | 1.2% | $2.0m | 6,300 | 0% | held |
| 31 | ISRG INTUITIVE SURGICAL INC | Healthcare | 1.2% | $2.0m | 4,908 | -23% | reduced |
| 32 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.2% | $1.9m | 47,861 | – | new |
| 33 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 1.1% | $1.8m | 181,588 | – | new |
| 34 | EQ EQUILLIUM INC | 1.1% | $1.8m | 552,956 | – | new | |
| 35 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.1% | $1.8m | 6,573 | – | new |
| 36 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 1.1% | $1.7m | 184,914 | -21% | reduced |
| 37 | CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 1.1% | $1.7m | 460,067 | -12% | reduced |
| 38 | VSTM VERASTEM INC | Healthcare | 1.0% | $1.6m | 429,041 | -33% | reduced |
| 39 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.0% | $1.6m | 22,417 | – | new |
| 40 | CLPT CLEARPOINT NEURO INC | 0.9% | $1.5m | 83,636 | – | new | |
| 41 | INSM INSMED INC | Healthcare | 0.9% | $1.5m | 13,873 | -48% | reduced |
| 42 | CAI CARIS LIFE SCIENCES INC | Healthcare | 0.9% | $1.4m | 78,180 | – | new |
| 43 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.8% | $1.4m | 18,359 | -73% | reduced |
| 44 | ZBIO ZENAS BIOPHARMA INC | 0.8% | $1.3m | 52,443 | -35% | reduced | |
| 45 | NBP NOVABRIDGE BIOSCIENCES | Healthcare | 0.7% | $1.1m | 576,960 | 0% | held |
| 46 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.7% | $1.1m | 13,100 | 0% | held |
| 47 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.5% | $889.3k | 47,531 | -83% | reduced |
| 48 | GERN GERON CORP | Healthcare | 0.5% | $798.8k | 624,046 | – | new |
| 49 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.4% | $709.7k | 10,110 | – | new |
| 50 | CMPX COMPASS THERAPEUTICS INC | 0.4% | $604.8k | 276,165 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.